These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Pentoxifylline and melatonin in combination with pioglitazone ameliorate experimental non-alcoholic fatty liver disease. Zaitone S, Hassan N, El-Orabi N, El-Awady el-S. Eur J Pharmacol; 2011 Jul 15; 662(1-3):70-7. PubMed ID: 21549113 [Abstract] [Full Text] [Related]
29. Nutritional assessment and hepatic fatty acid composition in non-alcoholic fatty liver disease (NAFLD): a cross-sectional study. Allard JP, Aghdassi E, Mohammed S, Raman M, Avand G, Arendt BM, Jalali P, Kandasamy T, Prayitno N, Sherman M, Guindi M, Ma DW, Heathcote JE. J Hepatol; 2008 Feb 15; 48(2):300-7. PubMed ID: 18086506 [Abstract] [Full Text] [Related]
30. Rutin inhibits oleic acid induced lipid accumulation via reducing lipogenesis and oxidative stress in hepatocarcinoma cells. Wu CH, Lin MC, Wang HC, Yang MY, Jou MJ, Wang CJ. J Food Sci; 2011 Mar 15; 76(2):T65-72. PubMed ID: 21535797 [Abstract] [Full Text] [Related]
31. [The relationship between the opening of mitochondrial permeability transition pores of cultured hepatocytes with their apoptoses in a non-alcoholic fatty liver disease model]. Chen DF, Wang CH. Zhonghua Gan Zang Bing Za Zhi; 2007 Nov 15; 15(11):837-9. PubMed ID: 18073067 [Abstract] [Full Text] [Related]
32. Protective effect of the Y220C mutant p53 against steatosis: good news? Gori M, Barbaro B, Arciello M, Maggio R, Viscomi C, Longo A, Balsano C. J Cell Physiol; 2014 Sep 15; 229(9):1182-92. PubMed ID: 24395441 [Abstract] [Full Text] [Related]
33. Intracellular and extracellular miRNome deregulation in cellular models of NAFLD or NASH: Clinical implications. Di Mauro S, Ragusa M, Urbano F, Filippello A, Di Pino A, Scamporrino A, Pulvirenti A, Ferro A, Rabuazzo AM, Purrello M, Purrello F, Piro S. Nutr Metab Cardiovasc Dis; 2016 Dec 15; 26(12):1129-1139. PubMed ID: 27756518 [Abstract] [Full Text] [Related]
34. Paraoxonase-1 activity, malondialdehyde and glutathione peroxidase in non-alcoholic fatty liver disease and the effect of atorvastatin. Samy W, Hassanian MA. Arab J Gastroenterol; 2011 Jun 15; 12(2):80-5. PubMed ID: 21684478 [Abstract] [Full Text] [Related]
35. Palmitic acid induces production of proinflammatory cytokine interleukin-8 from hepatocytes. Joshi-Barve S, Barve SS, Amancherla K, Gobejishvili L, Hill D, Cave M, Hote P, McClain CJ. Hepatology; 2007 Sep 15; 46(3):823-30. PubMed ID: 17680645 [Abstract] [Full Text] [Related]
36. Heme oxygenase-1 levels and oxidative stress-related parameters in non-alcoholic fatty liver disease patients. Malaguarnera L, Madeddu R, Palio E, Arena N, Malaguarnera M. J Hepatol; 2005 Apr 15; 42(4):585-91. PubMed ID: 15763346 [Abstract] [Full Text] [Related]